Choose a Drug ! Aciphex Acomplia Actos Acyclovir Allegra Alli Diet Drug Altace Ambien Amoxicillin Atenolol Ativan Augmentin Avandia Avapro Baclofen Bactrim Biaxin Celebrex Celexa Cephalexin Champix Cialis Cipro Claritin D Clomid Coreg Depakote Diflucan Dilantin Diovan Doxycycline Effexor XR Elavil Estradiol Flomax Flonase Fluoxetine Folic Acid Fosamax Glucophage Hydroxyzine Ibuprofen Imitrex Keflex Lamisil Lasix Levaquin Levitra Lexapro Lipitor Mobic Naproxen Neurontin Nexium Norvasc Omeprazole Paxil Plavix Premarin Prevacid Promethazine Propecia Proscar Protonix Reductil Reglan Remeron Risperdal Singulair Sonata Synthroid Tamiflu Topamax Trazodone Ultra "C" tabs Ultra "L" tabs Ultra "V" tabs Ultram Viagra Wellbutrin Xenical Zithromax Zocor Zoloft Zyban Zyprexa Zyrtec

September 2007 August 2007 July 2007 June 2007 May 2007 April 2007 March 2007 February 2007 January 2007 December 2006 November 2006 October 2006 September 2006 August 2006 July 2006 June 2006 May 2006 April 2006 March 2006 February 2006

Opt-in for Free Newsletter, special discount offers, drugs information & latest pharmacy news.

Priligy all Set to be launched in Britain

Premature ejaculation prevention drug Priligy is all set to be launched in Britain with 'the potential to do as much for men's sexual health as Viagra'. According to a report by “The Sun” Priligy tablet is to be taken 1 to 3 hours before sex and it is shown to make men last three times as long. Priligy is available for men aged 18 to 64.

The drug, costing 76 pounds for a pack of three 30mg tablets, works by changing the levels of a chemical in the brain, which helps a man to have more control over delaying the moment. Premature Ejaculation affects nearly 30 percent of all British men.

'Priligy has the potential to do as much for men's sexual health as Viagra. It will give sufferers a chance to improve the quality of their relationships and their general wellbeing,' Nitin Makadia, head of male sexual health at Lloyds-pharmacy, was quoted as saying. 'It has been well received by men elsewhere in Europe and we are really pleased to be bringing this treatment to the UK.'